Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Polo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Presse Medicale (Paris, France : 1983)|September 4, 2013
Thymic tumours: an updateValentina Polo, Nicolas Girard, Benjamin Besse
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 18, 2011
An unusual mediastinal outlineAlberto Banzato, Roberta Polverosi, Valentina Polo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
European Journal of Dermatology : EJD|March 3, 2017
Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumabIrene Russo, Giorgia Sacco, Stefano Frega, et al.
Cancers|June 26, 2026
Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient DataLorenzo Gasperoni, Tiziano Lupi, Luna Del Bono, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Anticancer Research|December 11, 2012
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM)Giulia Pasello, Giuseppe Marulli, Valentina Polo, et al.
Palliative & Supportive Care|August 22, 2023
The role of family functioning, attachment style, and care setting on pre-loss grief symptoms and burden in caregivers of terminally cancer patientsCarlo Lai, Chiara Ciacchella, Gaia Romana Pellicano, et al.
International Journal of Molecular Sciences|December 22, 2019
Detection of Loss of Heterozygosity in cfDNA of Advanced <i>EGFR</i>- or <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer PatientsElisa Boldrin, Giorgia Nardo, Elisabetta Zulato, et al.
Anticancer Research|April 12, 2015
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancerGiulia Pasello, Paolo Carli, Fabio Canova, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Presse Medicale (Paris, France : 1983)|September 4, 2013
Thymic tumours: an updateValentina Polo, Nicolas Girard, Benjamin Besse
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 18, 2011
An unusual mediastinal outlineAlberto Banzato, Roberta Polverosi, Valentina Polo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
European Journal of Dermatology : EJD|March 3, 2017
Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumabIrene Russo, Giorgia Sacco, Stefano Frega, et al.
Cancers|June 26, 2026
Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient DataLorenzo Gasperoni, Tiziano Lupi, Luna Del Bono, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Anticancer Research|December 11, 2012
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM)Giulia Pasello, Giuseppe Marulli, Valentina Polo, et al.
Palliative & Supportive Care|August 22, 2023
The role of family functioning, attachment style, and care setting on pre-loss grief symptoms and burden in caregivers of terminally cancer patientsCarlo Lai, Chiara Ciacchella, Gaia Romana Pellicano, et al.
International Journal of Molecular Sciences|December 22, 2019
Detection of Loss of Heterozygosity in cfDNA of Advanced <i>EGFR</i>- or <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer PatientsElisa Boldrin, Giorgia Nardo, Elisabetta Zulato, et al.
Anticancer Research|April 12, 2015
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancerGiulia Pasello, Paolo Carli, Fabio Canova, et al.
Pageof 3